Clinical Trials
24 trialsA Study of Surgery and Radiotherapy in People With Breast Cancer
Memorial Sloan Kettering Cancer Center
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
Case Comprehensive Cancer Center
Temporal Immunologic Changes With Hypofractionated Radiation-Induced DNA Damage in Breast Cancer
M.D. Anderson Cancer Center
Reinvigorating TNBC Response to Immunotherapy With Combination Myeloid Inhibition and Radiation
Cedars-Sinai Medical Center
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
Emory University
BREAST
University Hospital Heidelberg
RAY-no-BAN
Turku University Hospital
MOMENTUM
UMC Utrecht
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast Cancer
Memorial Sloan Kettering Cancer Center
OLIGAMI
Tokyo Medical and Dental University
Manual Lymphatic Drainage Breast Massage in Breast Cancer Patients After Breast Conserving Surgery
University of Southern California
FAST NOVEMBER
University of Utah
Outcomes and Cosmesis With Whole Breast Irradiation and Boost
University of Wisconsin, Madison
Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer
Hebei Medical University Fourth Hospital
Triple Negative Breast Cancer and Celecoxib. Pilot Study
Université de Sherbrooke
PRATO
Weill Medical College of Cornell University
COMBaRT
Fondazione Policlinico Universitario Campus Bio-Medico
Clinical Efficacy and Safety Assessment of Breast-Conserving Surgery for Central Breast Cancer: A Prospective Randomized Controlled Trial
Xijing Hospital
SAHARA-01
Institut du Cancer de Montpellier - Val d'Aurelle
A Prospective, Multicenter, Observational Cohort Study Assessing the Efficacy and Safety of Radiotherapy-sensitized Immunotherapy in Advanced Breast Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase II Clinical Trial of PD-L1 in Combination with Vinorelbine + Cyclophosphamide + Capecitabine (VEX) Metronomic Chemotherapy with or Without Radiotherapy for Advanced Triple-negative Breast Cancer.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
LARA
Instituto do Cancer do Estado de São Paulo
Preoperative Radiotherapy and Systemic Therapy Following Surgery in 'de Novo' Metastatic Breast Cancer
Ankara Oncology Research and Training Hospital
A Study of the Efficacy and Safety of Camrelizumab Plus Radiotherapy for Patients With Early Triple-Negative Breast
Jiangxi Provincial Cancer Hospital